Lupus & antiphospholipid syndrome
Development and psychometric evaluation of a physician global assessment for type 2 systemic lupus erythematosus symptoms
Authors' conclusion
The Type 2 PGA performed well as a physician-reported measure of type 2 SLE symptoms.
Study context
- Population
- Patients with SLE enrolled in the Duke Lupus Registry; Type 2 PGA rated by six rheumatologists of one academic lupus clinic6 rheumatologists
- Participants
- 263 patients
- Outcome
- Psychometric performance of the Type 2 PGA
Methodological detailssingle academic lupus clinic, prospectively collected registry data, consensus roundtable, Roundtable discussion to establish consensus guidelines for scoring the Type 2 PGA
- Single academic lupus clinic
- Prospectively collected registry data
- Consensus roundtable
- Roundtable discussion to establish consensus guidelines for scoring the Type 2 PGA
Recommendations
As reported in the abstract
- Intra-rater and inter-rater reliability (intraclass correlation coefficient)
- 0.83
- Correlation with patient-reported polysymptomatic distress (r)
- 0.76
- Correlation with patient-reported fatigue (r)
- 0.68
- Correlation with patient-reported cognitive dysfunction (r)
- 0.63
- Correlation with patient-reported waking unrefreshed (r)
- 0.62
- Correlation with patient-reported forgetfulness (r)
- 0.60
Original publication
Development and psychometric evaluation of a physician global assessment for type 2 systemic lupus erythematosus symptoms. Lupus Sci Med. Published 17 December 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →